Top Pharmaceutical Companies in San Francisco Bay Area, CA (149)

GoodRx is America’s healthcare marketplace. Each month, millions of people visit goodrx.com to find reliable health information and discounts for their healthcare — and we’ve helped people save $35 billion since 2011. We provide prescription discounts that are accepted at more than 70,000 pharmacies in the U.S., as well as telehealth services including doctor visits and lab tests. Our goal is...

Drug Hunter™ is an essential subscription service for R&D-focused organizations turning molecules into medicines. Every day, drug discovery strategies, tactics, challenges and solutions are disclosed, but the knowledge is fragmented across journals, conferences, patents, databases, news, company reports, filings and endless other sources, making it challenging to find and apply. Drug Hunter’s experts keep you current by connecting the dots, distilling industry...

IPS-Integrated Project Services, LLC, a Berkshire Hathaway company, is a global leader in developing innovative solutions for the consulting, architecture, engineering, project controls, procurement, construction management, and CQV of technically complex facilities worldwide. With technical expertise spanning R&D to pilot-scale to large-scale production, our team specializes in the technology, trends, and regulatory environment to successfully deliver capital projects and improve...

FibroGen, Inc., headquartered in San Francisco, with subsidiary offices in Beijing and Shanghai, is a leading biopharmaceutical company committed to discovering, developing, and commercializing a pipeline of first-in-class therapeutics. The Company applies its pioneering expertise in connective tissue growth factor (CTGF) biology and hypoxia-inducible factor (HIF) to advance innovative medicines for the treatment of unmet needs. Pamrevlumab, an anti-CTGF human...

At BioNex Solutions, we develop instrumentation and integrated systems that solve the most demanding applications in biopharmaceutical, biotech, and academic research. Our hardware and software philosophy is to design single-purpose, high performance modules, and integrate them to produce the desired functionality. Rather than push a single, generalized product that tries to meet the needs of every customer, we prefer to...

We are a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases with high unmet medical need. Seladelpar is a potent, selective, orally active PPARδ agonist in development for the treatment of patients with the autoimmune liver disease, primary biliary cholangitis (PBC). Our pipeline also includes additional investigational products and lead...

Caribou is a clinical-stage biopharmaceutical company, founded by pioneers in CRISPR genome editing, leveraging our proprietary technology to develop genome-edited off-the-shelf immune cell therapies for the treatment of cancer. We believe that cell therapies are critical now and for the future of cancer therapy and that advanced genome editing is necessary to develop sophisticated cell therapies to treat a variety...

Technical Safety Services is a leading provider of testing, inspection, certification, and calibration (TICC) services, specializing in controlled environments such as cleanrooms, fume hoods, and biosafety cabinets. The company serves highly regulated industries, including biotechnology, pharmaceuticals, aerospace, medical devices, and healthcare, ensuring compliance for laboratories, hospitals, and pharmacies.

Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for generations to come. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. More than 52,000 employees serve over 130 markets in the three business...

Celerion, a leader in early clinical research, delivers Applied Translational Medicine. Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines. With over 50 years of experience and 600 global clinic beds (including 24 in-hospital),...

Nuvation Bio is a global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s portfolio includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of...

At Mendel.ai, our mission is to use our novel AI aided by clinical experts to streamline global oncology research by organizing real world data and automating clinical trials. We build software to solve problems at each stage of the clinical trial process, from feasibility to post-trial pharmacovigilance. We strive for excellency, to be authentic and original, and to make a...

Novotech is a global full‑service clinical research organization (CRO) and scientific advisory partner that provides clinical trial execution, regulatory, laboratory and consulting services to biotech and small- to mid‑sized pharmaceutical companies. Operating across the Asia‑Pacific region and beyond with multiple offices and strategic site partnerships, Novotech helps sponsors accelerate development and access diverse patient populations for global drug development.

ICU Medical connects patients and caregivers through safe, life-saving, life-enhancing IV therapy systems, software, solutions, and consumables.

Menten AI pioneers generative AI to design cyclic peptide therapeutics and protein drugs/enzymes for therapeutic and industrial purposes, utilizing machine learning, quantum computing, and physics-based models.

We’re excited to share Alexza’s new corporate identity. It’s a brand that expresses our evolution and brings us closer to Ferrer, our parent company since 2016. We’re moving forward and, at the same time, staying true to our objective of offering high-quality pharmaceutical products for the acute treatment of disease, in order to make a positive impact in society. We...

Ardelyx is a publicly traded biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx's first approved product, IBSRELA® (tenapanor) is available in the United States. Ardelyx is developing XPHOZAH® (tenapanor), a novel product candidate to control serum phosphorus in adult patients with CKD on dialysis, which has completed...

ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company focused on overcoming resistance in cancer. It develops precision medicines intended to make existing cancer therapies more effective and durable. Its clinical-stage candidates include rinzimetostat (ORIC-944), an EED/PRC2 inhibitor being developed for prostate cancer, and enozertinib, a brain-penetrant inhibitor targeting EGFR and HER2 exon 20 and EGFR atypical mutations across genetically defined cancers,...

GondolaBio is a clinical-stage biopharmaceutical company focused on developing novel medicines for patients living with genetic diseases.

Evommune is a clinical-stage biotechnology company focused on discovering and developing novel therapies for immune-mediated chronic inflammatory diseases. Its mission is to improve patients’ daily lives and prevent the long-term effects of uncontrolled inflammation. The company advances a portfolio of differentiated product candidates designed to target key drivers of chronic inflammation, with the goal of addressing serious diseases where existing...